| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |